Nestle has a newly-acquired company, and it is the protein shake maker, Orgain. The latter produces plant-based bars, shakes, and protein powders, and the Swiss multinational food and drink processing company headquartered in Vevey, Vaud, Switzerland, bought a majority stake for an undisclosed amount.
Andrew Abraham, Orgain's founder, and Butterfly Equity will remain shareholders of the company once the deal is completed. According to Food Dive, the agreement between Nestle and Orgain includes the option for the former to buy the rest of the shares in the company in 2024. Abraham will also retain his position as the chief executive officer of Orgain.
It was said that the stake acquisition will push and step up Nestlé's efforts to grow its health and wellness business unit. To attain its goal, the company will also be removing some of its divisions that are growing slowly compared to the others.
In fact, Nestlé already offloaded its confections and ice cream businesses and last year, it has also disposed of the majority of its North American bottled waters business for $4.3 billion as it was already struggling to stay afloat.
With its new deal with Orgain, Nestle will also be able to focus more on its other international premium brands that have big potential to grow further such as Perrier. Orgain will also give the firm fresh products to offer especially with the growing demand for plant-based items around the world. Furthermore, Orgain will give Nestle a deeper presence in trendy categories that are becoming really popular with consumers.
"Nutritional protein plays a key role in supporting our health and wellness, whether we enjoy an active lifestyle or are facing health challenges," Nestlé Health Science chief executive officer, Greg Behar, said in a press release. "Orgain's emphasis on clean, all natural, plant-based, organic ingredients has made it a leader in the U.S., and we look forward to combining our companies' expertise to bring Orgain to more people around the world."
Dr. Abraham, CEO and Founder of Orgain, also said, "We've worked hard to develop innovative products that make a real difference in consumers' lives, and now through Nestlé Health Science's capabilities, resources and dedication to nutrition, we will be able to reach more people around the world."
Meanwhile, the acquisition deal is still subject to customary regulatory approvals.


Asian Currencies Slip as US Dollar Gains on Rising Iran Tensions and Awaited Jobs Data
Continental AG Shares Jump After Q1 Profit Beats Expectations
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments
JD Sports Backs Nike CEO Elliott Hill Amid Brand Turnaround Efforts
Trump-Xi Meeting 2026: U.S.-China Trade Tensions Escalate Ahead of Beijing Summit
Lufthansa Q1 Loss Narrows as Strong Summer Travel Demand Boosts Outlook
Maersk Q1 Earnings Beat Expectations as Iran Conflict Clouds Shipping Outlook
CoreWeave Q1 2026 Revenue Surges as AI Infrastructure Demand Grows
Russian LNG Shadow Fleet Expands Amid Arctic LNG 2 Sanctions
Armani Group Eyes Strategic Stake Sale to Luxury Giants
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand
Dollar Slips as Strong U.S. Jobs Data Reduces Fed Rate Cut Expectations
China Banks Halt New Loans to Sanctioned Refineries Amid U.S.-Iran Oil Crackdown
Asian Stocks Rally as Japan’s Nikkei Hits Record High on U.S.-Iran Peace Optimism
US-Iran Ceasefire Under Pressure as Fresh Strait of Hormuz Clashes Shake Oil Markets
Shell Q1 Profit Surges to Two-Year High as Dividend Rises Despite War-Driven Debt Pressure
Trump Signals Possible U.S.-Iran Peace Deal as Markets Rally on Hopes of War Ending 



